Indication and Safety Information

Thermi’s temperature-controlled RF system, ARVATI, is indicated: 
For use in dermatological and general surgical procedures for electrocoagulation and hemostasis. To create lesions in nervous tissue.
Important Safety Considerations:
Thermi® radiofrequency products should not be used on patients who are pregnant, have a fever or skin infection in or around the area of application. Expected procedure side effects may include transient pain in procedure area, erythema and edema.
This site is intended for US use.

©2019 ThermiGen, LLC. All rights reserved

Log in with your credentials

Forgot your details?